Please login to the form below

Not currently logged in

The inVentiv Health Communications Award for Excellence in Healthcare Collaboration and Partnerships

Sponsored by

Back to Results


Maintaining Adherence Programme

by Janssen with support from Havas Lynx

Summary of work

Winner: by Janssen with support from Havas Lynx

SEPT, a UK leader in the provision of mental health and community services, and Janssen, with its long heritage in psychiatry, came together to explore potential opportunities for joint working. Having identified shared values and strategic priorities they agreed to work together to test an innovative model of disease management in the UK that had the potential to significantly improve the pathway for people with schizophrenia, bipolar and affective disorders. This exciting undertaking placed digital innovation at the core, allowing aligned interests and shared values to deliver transformational innovation in healthcare provision and improved outcomes for patients. To date, the Maintaining Adherence Programme (MAP) has delivered: outstanding patient, carer and staff experience/satisfaction results, considerable reduction in hospital admissions and significant improvements in efficiency/cost savings.

Judges comments

We really liked this effective collaboration between Janssen and SEPT to address the massive societal impact of poor adherence in patients with schizophrenia. We saw tangible and impressive patient outcomes in the form of significantly reduced hospital admissions and bed days - both fulfilling the QIPP agenda.


Improving Anaphylaxis Treatment – A North West Initiative - by ALK-Abelló Ltd

The London Joint Working Group on Substance Misuse and Hepatitis C (LJWG) - by LJWG with support from Dovetail Strategies funded by: Janssen, MSD, Reckitt Benckiser Pharmaceuticals, and Roche Products

Addressing the Base of the Pyramid - by Novo Nordisk A/S with support from Lagos State Government, General Hospital Ikorodu and Sunny Kuku Foundation

Helping foster an unlikely partnership between Endocrinologists and Nephrologists: the European Hyponatraemia Network (EHN) - by Otsuka Pharmaceutical Europe Ltd. with support from Apothecom, a Huntsworth Health Company

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022